Methods:

• Computational screening: Large scale docking of FDA approved molecules.

• Binding assays: Experiments aimed at measuring the binding affinity of the FDA approved molecules on the target.

• Structural biology: Structural characterization of the binding of FDA approved molecules.

Targets:

• S protein: One of the Sars-Cov-2 surface proteins key for the binding to the host cells.